Drug Trial Radar · NCT07219407
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Dec 15, 2025
Primary completion
Feb 3, 2028
Study completion Feb 3, 2028
Sponsor
- Lead sponsor
- Rapport Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 21, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.
Conditions
- Focal Epilepsy
- Epilepsy
- Refractory Focal Epilepsy
- Seizure
- Focal Seizure
- Focal Onset Seizure
Interventions
RAP-219Drug
Participants will receive one RAP-219 0.125 mg capsule daily for 3 days followed by one 0.25mg tablet RAP-219 daily for 28 days, then one 0.75mg tablet daily for the remainder of the treatment period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse events (TEAEs)Time frame: From the start of RAP-219 treatment through 8 weeks after last dose, up to Week 112
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Clinical Study Center
Boise, Idaho · Recruiting
Clinical Study Center
Rochester, Minnesota · Recruiting
Clinical Study Center
New York, New York · Recruiting
Clinical Study Center
Cleveland, Ohio · Recruiting
Clinical Study Center
Philadelphia, Pennsylvania · Recruiting
Clinical Study Center
Nashville, Tennessee · Recruiting
Clinical Study Center
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.